MedPath

Physical Exercise Program in Obese and Overweight Pregnant Women

Not Applicable
Conditions
Pregnancy
Registration Number
NCT01753622
Lead Sponsor
Technical University of Madrid
Brief Summary

Obesity and overweight have become an epidemic in the world and its prevalence between pregnant women is especially dangerous. Having a high Body Mass Index (BMI) is also associated with depression disorders and its serious complications during this period.

Detailed Description

The aim of our study is to assess whether a specific exercise program during pregnancy has a positive effect on maternal mood and other pregnancy outcomes.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
150
Inclusion Criteria
  • Being healthy and able to exercise following American College of Obstetricians and Gynecologists (ACOG) guidelines
  • Being able to communicate in spanish
  • Giving birth at Hospital Universitario de Fuenlabrada
  • Having a Body Mass Index (BMI) greater than 24.9
Exclusion Criteria
  • Multiparity
  • Obstetrician complications
  • Being interested in the study after 18 weeks
  • Not being regular in physical exercise program (minimum adherence 80%)
  • Younger than 18 years old

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change from level of depression at the end of the pregnancyUp to 36 weeks

The Center for Epidemiological Studies-Depression scale (CES-D) was administered to all obese and overweight pregnant women at the beginning and at the end of their pregnancies

Secondary Outcome Measures
NameTimeMethod
Maternal gestational weight gain40-42 weeks

Maternal gain weight

Maternal outcomesAfter labor

Type of labor

Trial Locations

Locations (1)

Universidad Politecnica de Madrid

🇪🇸

Madrid, Spain

Universidad Politecnica de Madrid
🇪🇸Madrid, Spain
Maria Perales, PhD student
Principal Investigator
Ruben Barakat, PhD
Contact
913364020
barakatruben@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.